Christopher Yanick

411 total citations
7 papers, 96 citations indexed

About

Christopher Yanick is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Christopher Yanick has authored 7 papers receiving a total of 96 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cellular and Molecular Neuroscience, 4 papers in Molecular Biology and 2 papers in Neurology. Recurrent topics in Christopher Yanick's work include Hereditary Neurological Disorders (4 papers), Genetic Neurodegenerative Diseases (3 papers) and Mitochondrial Function and Pathology (2 papers). Christopher Yanick is often cited by papers focused on Hereditary Neurological Disorders (4 papers), Genetic Neurodegenerative Diseases (3 papers) and Mitochondrial Function and Pathology (2 papers). Christopher Yanick collaborates with scholars based in United States, France and Canada. Christopher Yanick's co-authors include Nicolas Wein, Júlia Teixeira Oliveira, Lauren M. Byrne, Ihn Sik Seong, Amber L. Southwell, Nalini Potluri, Yuanyun Xie, Hyeongju Kim, Ibolya E. András and Michał Toborek and has published in prestigious journals such as Journal of Neuroscience, Brain and Frontiers in Cellular Neuroscience.

In The Last Decade

Christopher Yanick

6 papers receiving 96 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Yanick United States 5 63 54 25 11 10 7 96
Natalia Dominik United Kingdom 5 83 1.3× 66 1.2× 21 0.8× 7 0.6× 10 1.0× 12 109
Ján Necpál Slovakia 6 24 0.4× 29 0.5× 42 1.7× 9 0.8× 11 1.1× 19 87
Teisha Y. Bradshaw United Kingdom 5 72 1.1× 113 2.1× 14 0.6× 15 1.4× 21 2.1× 6 133
Eva Maria C. Cutiongco–de la Paz Philippines 5 39 0.6× 35 0.6× 41 1.6× 6 0.5× 8 0.8× 17 118
Agustí Rodríguez‐Palmero Spain 6 19 0.3× 84 1.6× 8 0.3× 6 0.5× 8 0.8× 11 118
Elisabeth Ollagnon France 4 50 0.8× 42 0.8× 25 1.0× 6 0.5× 9 0.9× 6 84
Nicola Roberts United Kingdom 5 29 0.5× 142 2.6× 15 0.6× 14 1.3× 4 0.4× 6 196
Andrew Singleton United States 4 20 0.3× 45 0.8× 14 0.6× 10 0.9× 7 0.7× 5 90
Grace Salsbury United Kingdom 4 39 0.6× 73 1.4× 15 0.6× 4 0.4× 3 0.3× 4 86
Johanna Huttenlocher Germany 3 26 0.4× 40 0.7× 46 1.8× 8 0.7× 13 1.3× 3 101

Countries citing papers authored by Christopher Yanick

Since Specialization
Citations

This map shows the geographic impact of Christopher Yanick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Yanick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Yanick more than expected).

Fields of papers citing papers by Christopher Yanick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Yanick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Yanick. The network helps show where Christopher Yanick may publish in the future.

Co-authorship network of co-authors of Christopher Yanick

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Yanick. A scholar is included among the top collaborators of Christopher Yanick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Yanick. Christopher Yanick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Rebelo, Adriana, Clemer Abad, Maike F. Dohrn, et al.. (2024). SORD-deficient rats develop a motor-predominant peripheral neuropathy unveiling novel pathophysiological insights. Brain. 147(9). 3131–3143. 5 indexed citations
2.
Yanick, Christopher, et al.. (2024). Generation of 3 patient induced Pluripotent stem cell lines containing SORD mutations linked to a recessive neuropathy. Stem Cell Research. 78. 103449–103449.
3.
Rebelo, Adriana, Matt C. Danzi, Sitong Chen, et al.. (2024). Customized antisense oligonucleotide-based therapy for neurofilament-associated Charcot–Marie–Tooth disease. Brain. 147(12). 4227–4239. 2 indexed citations
4.
Oliveira, Júlia Teixeira, et al.. (2023). Neuron-Schwann cell interactions in peripheral nervous system homeostasis, disease, and preclinical treatment. Frontiers in Cellular Neuroscience. 17. 1248922–1248922. 21 indexed citations
5.
Zhu, Yi, Adriana Rebelo, Sheyum Syed, et al.. (2023). Sorbitol reduction via govorestat ameliorates synaptic dysfunction and neurodegeneration in sorbitol dehydrogenase deficiency. JCI Insight. 8(10). 11 indexed citations
6.
Caron, Nicholas S., Christopher Yanick, Amirah E.-E. Aly, et al.. (2020). Mutant Huntingtin Is Cleared from the Brain via Active Mechanisms in Huntington Disease. Journal of Neuroscience. 41(4). 780–796. 46 indexed citations
7.
András, Ibolya E., et al.. (2020). Extracellular vesicle-mediated amyloid transfer to neural progenitor cells: implications for RAGE and HIV infection. Molecular Brain. 13(1). 21–21. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026